- Home
- CXM vs CERT Comparison
CXM vs CERT Comparison
Compare CXM & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXM
- CERT
- Stock Information
- Founded
- CXM 2009
- CERT 2008
- Country
- CXM United States
- CERT United States
- Employees
- CXM N/A
- CERT N/A
- Industry
- CXM Computer Software: Prepackaged Software
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- CXM Technology
- CERT Technology
- Exchange
- CXM Nasdaq
- CERT Nasdaq
- Market Cap
- CXM 1.8B
- CERT 1.6B
- IPO Year
- CXM 2021
- CERT 2020
- Fundamental
- Price
- CXM $7.67
- CERT $9.95
- Analyst Decision
- CXM Hold
- CERT Buy
- Analyst Count
- CXM 13
- CERT 7
- Target Price
- CXM $9.68
- CERT $15.92
- AVG Volume (30 Days)
- CXM 3.1M
- CERT 1.2M
- Earning Date
- CXM 12-04-2024
- CERT 11-06-2024
- Dividend Yield
- CXM N/A
- CERT N/A
- EPS Growth
- CXM 566.50
- CERT N/A
- EPS
- CXM 0.17
- CERT N/A
- Revenue
- CXM $773,698,000.00
- CERT $372,797,000.00
- Revenue This Year
- CXM $8.44
- CERT $10.39
- Revenue Next Year
- CXM $4.31
- CERT $10.57
- P/E Ratio
- CXM $44.94
- CERT N/A
- Revenue Growth
- CXM 14.72
- CERT 5.62
- 52 Week Low
- CXM $6.91
- CERT $9.88
- 52 Week High
- CXM $17.14
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- CXM 51.09
- CERT 41.17
- Support Level
- CXM $7.47
- CERT $10.54
- Resistance Level
- CXM $8.33
- CERT $11.37
- Average True Range (ATR)
- CXM 0.33
- CERT 0.39
- MACD
- CXM 0.05
- CERT 0.03
- Stochastic Oscillator
- CXM 47.20
- CERT 23.86
About CXM Sprinklr Inc.
Sprinklr Inc is engaged in providing enterprise software that enables every customer-facing function across the front office, from Customer Care to Marketing, to collaborate across internal silos, and communicate across digital channels. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in Americas, EMEA and other countries. It derives maximum revenue from Americas.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.